The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565 · cited 1×
“This advantage of colloidal carriers has been attributed to the so-called enhanced permeability and retention (EPR) effect [24,25], whereby macromolecules and nanoparticles, even as large as 300nm, are able to extravasate into the tumor interstitium through the hyperpermeable vasculature of most solid tumors [15,26].”
BackgroundWang, Y.-X. J., Hussain, S. M., & Krestin, G. P. (2001) · European Radiology · doi:10.1007/s003300100908 · Cited by 1,381
Locoregional cancer treatment with magnetic drug targeting.
Alexiou, C., Arnold, W. J., Klein, R. J., Parak, F., Hulin, P., Bergemann, C., Erhardt, W. D., Wagenpfeil, S., & Lübbe, A. S. (2000) · PubMed · Cited by 863
Self-citationClinical Applications of Magnetic Drug Targeting
Lübbe, A. S., Alexiou, C., & Bergemann, C. (2001) · Journal of Surgical Research · doi:10.1006/jsre.2000.6030 · Cited by 844
Self-citationMicroscopic susceptibility variation and transverse relaxation: Theory and experiment
Weisskoff, R., Zuo, C. S., Boxerman, J. L., & Rosen, B. R. (1994) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910310605 · Cited by 715
Lübbe, A. S., Bergemann, C., Riess, H. B., Schriever, F., Reichardt, P., Possinger, K., Matthias, M., Dörken, B., Herrmann, F., Gürtler, R., et al. (1996) · PubMed · Cited by 652
Self-citationJung, C. W., & Jacobs, P. (1995) · Magnetic Resonance Imaging · doi:10.1016/0730-725x(95)00024-b · Cited by 622
Significant Transport of Doxorubicin into the Brain with Polysorbate 80-Coated Nanoparticles
Gulyaev, A. E., Gelperina, S. E., Skidan, I. N., Antropov, A. S., Kivman, G. Y., & Kreuter, J. (1999) · Pharmaceutical Research · doi:10.1023/a:1018983904537 · Cited by 521
Vascular Targeted Nanoparticles for Imaging and Treatment of Brain Tumors
Reddy, G. R., Bhojani, M. S., McConville, P., Moody, J., Moffat, B. A., Hall, D. E., Kim, G., Koo, Y.-E. L., Woolliscroft, M. J., Sugai, J. V., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0946 · Cited by 491
Self-citationNoguchi, Y., Wu, J., Duncan, R., Strohalm, J., Ulbrich, K., Akaike, T., & Maeda, H. (1998) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1998.tb00563.x · Cited by 470
Long-circulating iron oxides for MR imaging
Weissleder, R., Bogdanov, A., Neuwelt, E. A., & Papisov, M. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00033-4 · Cited by 398
Preclinical experiences with magnetic drug targeting: tolerance and efficacy.
Lübbe, A. S., Bergemann, C., Huhnt, W., Fricke, T., Riess, H. B., Brock, J., & Huhn, D. (1996) · PubMed · Cited by 397
Self-citationHuenges, E., Parak, F., Alexiou, C., Jurgons, R., Schmid, R. J., Bergemann, C., Henke, J., & Erhardt, W. (2003) · Journal of Drug Targeting · doi:10.1080/1061186031000150791 · Cited by 293
Self-citationPrinciples of cerebral perfusion imaging by bolus tracking
Østergaard, L. (2005) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.20460 · Cited by 289
Son, Y. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00231-1 · Cited by 267
Tamargo, R. J., Myseros, J. S., Epstein, J. I., Yang, M. B., Chasin, M., & Brem, H. (1993) · PubMed · Cited by 247
Targeted therapy for brain tumours
Lesniak, M. S., & Brem, H. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1414 · Cited by 234
Siegal, T., Horowitz, A., & Gabizon, A. (1995) · Journal of neurosurgery · doi:10.3171/jns.1995.83.6.1029 · Cited by 232
Saito, R., Bringas, J. R., McKnight, T. R., Wendland, M. F., Mamot, C., Drummond, D. C., Kirpotin, D. B., Park, J. W., Berger, M. S., & Bankiewicz, K. S. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3631 · Cited by 231
Vascular Microenvironment in Gliomas
Vajkoczy, P., & Menger, M. D. (2000) · Journal of Neuro-Oncology · doi:10.1023/a:1006474832189 · Cited by 167
A Novel Polyacrylamide Magnetic Nanoparticle Contrast Agent for Molecular Imaging using MRI
Moffat, B. A., Reddy, G. R., McConville, P., Hall, D. E., Chenevert, T. L., Kopelman, R. R., Philbert, M., Weissleder, R., Rehemtulla, A., & Ross, B. D. (2003) · Molecular Imaging · doi:10.1162/15353500200303163 · Cited by 158
Self-citationWidder, K. J., Morris, R. M., Poore, G. A., Howard, D. P., & Senyei, A. E. (1983) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(83)90408-x · Cited by 155
Cognitive Functioning and Quality of Life in Malignant Glioma Patients: A Review of the Literature
Weitzner, M. A., & Meyers, C. A. (1997) · Psycho-Oncology · doi:10.1002/(sici)1099-1611(199709)6:3<169::aid-pon269>3.0.co;2-# · Cited by 134
Neuwelt, E. A., Glasberg, M. R., Frenkel, E. P., & Barnett, P. A. (1983) · Annals of Neurology · doi:10.1002/ana.410140310 · Cited by 133
Modification of the blood-brain barrier in the chemotherapy of malignant brain tumors.
Neuwelt, E. A., & Рапопорт, С. И. (1984) · PubMed · Cited by 129
Distribution of Small Magnetic Particles in Brain Tumor-bearing Rats
Pulfer, S. K., Ciccotto, S. L., & Gallo, J. M. (1999) · Journal of Neuro-Oncology · doi:10.1023/a:1006137523591 · Cited by 107
Primary brain tumors: review of etiology, diagnosis and treatment.
Hb, N. (1994) · PubMed · Cited by 103
Penetration of intra-arterially administered vincristine in experimental brain tumor
Boyle, F. M., Eller, S., & Grossman, S. A. (2004) · Neuro-Oncology · doi:10.1215/s1152851703000516 · Cited by 102
Targeted drug delivery for brain cancer treatment
Gutman, R. L., Peacock, G., & Lu, D. R. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00229-1 · Cited by 87
Simonsen, C. Z., ��stergaard, L., Vestergaard‐Poulsen, P., Røhl, L., Bj�rnerud, A., & Gyldensted, C. (1999) · Journal of Magnetic Resonance Imaging · doi:10.1002/(sici)1522-2586(199902)9:2<342::aid-jmri29>3.0.co;2-b · Cited by 86
Ross, B. D., Zhao, Y.-J., Neal, E. R., Stegman, L. D., Ercolani, M. C., Ben‐Yoseph, O., & Chenevert, T. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.7012 · Cited by 84
Self-citationLiposome-Mediated Therapy of Intracranial Brain Tumors in a Rat Model
Sharma, U. S., Sharma, A., Chau, R. I., & Straubinger, R. M. (1997) · Pharmaceutical Research · doi:10.1023/a:1012136925030 · Cited by 79
Intravesical administration of doxorubicin to swine bladder using magnetically targeted carriers
Leakakos, T., Ji, C., Lawson, G., Peterson, C., & Goodwin, S. C. (2003) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-003-0597-9 · Cited by 79
Pharmacokinetic Considerations in the Treatment of CNS Tumours
Motl, S. E., Zhuang, Y., Waters, C. M., & Stewart, C. F. (2006) · Clinical Pharmacokinetics · doi:10.2165/00003088-200645090-00002 · Cited by 77
Malignant Gliomas in 2005: Where to GO From Here?
Fisher, P. G., & Buffler, P. A. (2005) · JAMA · doi:10.1001/jama.293.5.615 · Cited by 76
Glial brain tumor targeting of magnetite nanoparticles in rats
Mykhaylyk, O. M., Черченко, А. П., Ilkin, A., Dudchenko, N. O., Ruditsa, V., Novoseletz, M., & Zozulya, Y. (2001) · Journal of Magnetism and Magnetic Materials · doi:10.1016/s0304-8853(00)01264-6 · Cited by 74
Zhou, R., Mazurchuk, R., & Straubinger, R. M. (2002) · PubMed · Cited by 71
Enhanced Brain Tumor Selectivity of Cationic Magnetic Polysaccharide Microspheres
Pulfer, S. K., & Gallo, J. M. (1998) · Journal of drug targeting · doi:10.3109/10611869808997896 · Cited by 70
Heimberger, A. B., Archer, G. E., McLendon, R. E., Hulette, C., Friedman, A. H., Friedman, H. S., Bigner, D. D., & Sampson, J. H. (2000) · PubMed · Cited by 60
Evaluation of blood-brain barrier permeability and the effect of interferon in mouse glioma model
Wiranowska, M., Gonzalvo, A. A., Saporta, S., Gonzalez, O., & Prockop, L. D. (1992) · Journal of Neuro-Oncology · doi:10.1007/bf00172598 · Cited by 25
Cited by
Kango, S., Kalia, S., Celli, A., Njuguna, J., Habibi, Y., & Kumar, R. (2013) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2013.02.003 · Cited by 2,157
Joudeh, N., & Linke, D. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01477-8 · Cited by 1,908
Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging
Veiseh, O., Gunn, J. W., & Zhang, M. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.11.002 · Cited by 1,832
Biosynthesis of Nanoparticles by Microorganisms and Their Applications
Li, X., Xu, H., Chen, Z.-S., & Chen, G. (2011) · Journal of Nanomaterials · doi:10.1155/2011/270974 · Cited by 1,133
Introduction to metallic nanoparticles
Mody, V., Siwale, R., Singh, A., & Mody, H. (2010) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/0975-7406.72127 · Cited by 1,025
Metadata
- Authors
- Chertok, B., Moffat, B. A., David, A. E., Yu, F., Bergemann, C., Ross, B. D., & Yang, V. C.
- Venue
- Biomaterials
- Publisher
- Elsevier BV
- Published
- 2008-02
- Volume
- 29
- Issue
- 4
- Pages
- 487-496
- ISSN
- 0142-9612 (ISSN-L)
- OpenAlex
- W2075337839
- Cited by
- 900
- References
- 40
- FWCI
- 17.03
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.